Menu

Search

  |   Business

Menu

  |   Business

Search

SHAREHOLDER COMPLAINT: Levi & Korsinsky, LLP Files in U.S. District Court to Recover Losses Suffered by Investors in Ophthotech Corporation – Sets Lead Plaintiff Deadline of March 13, 2017

NEW YORK, Jan. 11, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired shares of Ophthotech Corporation (“Ophthotech”) (NASDAQ:OPHT) between May 11, 2015 and December 12, 2016. You are hereby notified that Levi & Korsinsky has commenced the class action Micholle v. Ophthotech Corporation, et al. (Case No. 1:17-cv-00210) in the USDC for the Southern District of New York. To get more information go to:

http://zlk.9nl.com/ophthotech

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that, throughout the Class Period, Ophthotech made overtly positive representations about the effectiveness and potential of its treatment Fovista when used in combination with Lucentis, a commercially available anti-vascular endothelial growth factor agent, despite awareness that the phase 3 clinical trial of Fovista would fail to achieve its primary endpoint of change in best corrected visual acuity from baseline at 12 months over Lucentis alone. The complaint further alleges that these statements caused Ophthotech stock to trade at artificially inflated prices.

On December 12, 2016, Ophthotech announced that the trial had failed to achieve its primary endpoint, and that Fovista and Lucentis demonstrated a non-statically significant improvement over patients only receiving Lucentis. Following this news, shares of Ophthotech fell approximately 86% to close at $5.29.

Take Action: if you suffered a loss in Ophthotech you have until March 13, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:  	
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor 
New York, NY 10004	
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

Primary Logo

  • ET PRO
  • Market Data

Market-moving news and views, 24 hours a day >

2017-01-20 15:26:23
0m

January 20 07:00 UTC Released

DEProducer Prices YY

Actual

1.0 %

Forecast

1.0 %

Previous

0.1 %

January 20 07:00 UTC Released

DEProducer Prices MM

Actual

0.4 %

Forecast

0.4 %

Previous

0.3 %

January 23 07:00 UTC 37803780m

TRConsumer Confidence*

Actual

Forecast

Previous

63.40

January 23 13:00 UTC 41404140m

SACPI YY*

Actual

Forecast

Previous

2.3 %

January 23 13:00 UTC 41404140m

SACPI MM*

Actual

Forecast

Previous

-0.2 %

January 23 13:30 UTC 41704170m

CAWholesale Trade MM

Actual

Forecast

Previous

1.1 %

January 23 15:00 UTC 42604260m

EZConsumer Confid. Flash

Actual

Forecast

Previous

-5.1 %

January 23 19:00 UTC 45004500m

ARAnnual Industrial Output*

Actual

Forecast

Previous

-2.5 %

January 23 21:00 UTC 46204620m

KRConsumer Sentiment Ind*

Actual

Forecast

Previous

94 bln $

January 24 00:30 UTC 48304830m

JPNikkei Mfg PMI

Actual

Forecast

Previous

52.4 %

Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.